| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5599628 | Atherosclerosis | 2017 | 9 Pages |
Abstract
In a large clinical cohort of CAD patients, Gal-3BP levels are independently associated with all-cause and cardiovascular mortality. The underlying mechanisms may likely involve metabolic and inflammatory distress. To further evaluate the potential clinical value of Gal-3BP, prospective studies are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christian A. Gleissner, Christian Erbel, Fabian Linden, Gabriele Domschke, Mohammadreza Akhavanpoor, Christian M. Helmes, Andreas O. Doesch, Marcus E. Kleber, Hugo A. Katus, Winfried Maerz,